#heartfailure search results
Simultaneous publication during #EHRA26 👇 Subclinical #afib and the risk of #HeartFailure: insights from ARTESiA ow.ly/H1Qp50YI7mz @EJHFEiC #EJHF
Endomyocardial biopsy plays a pivotal role in the diagnostic workup of myocarditis, cardiomyopathies, and unexplained acute heart failure. Careful patient selection and expertise are essential to optimise its risk–benefit profile. #cardiotwitter #heartfailure #cardiology 👉Read
In patients with #HeartFailure and #LBBB, conduction system pacing (#CSP) was inferior to biventricular pacing (#BiVP) for a composite of death, heart failure events, and LVEF change at 12 months. ja.ma/3O23Ef2
By repurposing BOLD-MRI neuroimaging for the heart, a team presents a needle-free, high-resolution #MRI technique that can accurately quantify myocardial oxygen consumption in large animals and patients with #HeartFailure in just 3 minutes. @ScienceTM scim.ag/4lNOjLi
🫀 Why do so many #HeartFailure patients never reach optimal medical therapy? Quadruple therapy (BB + RASi/ARNi + MRA + SGLT2i) is guideline-recommended for #HFrEF — yet adherence gaps remain a critical challenge. Barriers are multilayered: 🩺 Physician → guideline awareness,
#HeartFailure (HF) affects more than 64 million individuals worldwide, and acute HF is associated with 1-year mortality rates of 23.6% in North America and Europe. Cardiac resynchronization therapy restores synchronous ventricular activation in patients with HF, reduced LVEF,
facebook.com/share/v/1AjX19… Heart Failure: It's not just a weak pump. vascular dysfunction—arterial stiffness, microvascular issues, and neurohumoral activation—drives heart failure (HF) progression, not just weak heart muscle. #HeartFailure #VascularHealth #Cardiology
Left-sided Vs Right-sided Heart Failure #heartfailure #Nursing #Nclex #PNLE #MedTwt #NursingTwt #MedX
Among US veterans with #HeartFailure with reduced ejection fraction, fewer than one-quarter achieved quadruple guideline-directed medical therapy within 2.9 years, and medication copays were associated with lower rates of therapy achievement. ja.ma/412N0if
facebook.com/share/p/1FGk4z… Cardiorenal Pharmacotherapy: Mechanisms and Outcomes 🟥 RAASi — eGFR dip, MACE↓ 🟧 ARNI — NT-proBNP↓ 🟩 SGLT2i — proteinuria↓ 🟦 ns-MRA — fibrosis↓ 🟪 GLP-1 RA — HFH↓ #CardioRenal #HeartFailure #CKD #SGLT2i #ARNI #GLP1RA #Nephrology #Cardiology
New #JACC This Week is live 🎧 Drs. Carolyn Lam, @lamcardio, & Harlan Krumholz, @hmkyale, break down key studies from this week’s JACC issue, including new evidence on #Chagas‑related #heartfailure. Listen to the full podcast here: podcasts.apple.com/us/podcast/jac… #JACCPodcast
Patients with #HeartFailure showed increased myocardial fibroblast activation using [68Ga]FAPI-46 PET/MRI, with distinct patterns by cardiomyopathy etiology, highlighting activated fibroblasts as a potential therapeutic target. ja.ma/3QpBqvg
![JAMACardio's tweet image. Patients with #HeartFailure showed increased myocardial fibroblast activation using [68Ga]FAPI-46 PET/MRI, with distinct patterns by cardiomyopathy etiology, highlighting activated fibroblasts as a potential therapeutic target.
ja.ma/3QpBqvg](https://pbs.twimg.com/media/HF9stYPW4AAvEGM.jpg)
Food supplementation with medically tailored meals or fresh produce was feasible and well accepted in patients with #HeartFailure but did not reduce hospitalizations or emergency visits compared to usual care. ja.ma/3Qn4cg0
Enrollment in #HeartFailure-focused Chronic Condition Special Needs Plans did not demonstrate improved posthospitalization mortality or hospital revisit rates compared with conventional Medicare Advantage plans. ja.ma/4vlFNHR
Physician-directed patient self-management using ambulatory IVC-based congestion monitoring was feasible, assoc w/ increased signal-driven intervention, and not assoc w/ adverse safety signals. jacc.org/doi/10.1016/j.… #JACCHF #THT2026 #HeartFailure
Counting down to #HeartFailure26 Join your global community to explore the latest breakthroughs advancing prevention, diagnosis and treatment. Register by 9 April to save: bit.ly/4azSIh1 #HFA_ESC #HeartFailure @HFA_President
facebook.com/share/p/1CNexo… This apical three-chamber view highlights the structural remodeling across primary cardiomyopathies. Key features include ventricular hypertrophy (HCM), ventricular dilation with impaired systolic function (DCM. #Cardiology #Cardiomyopathy #HeartFailure 🫀
Expanding Horizons: HFmrEF & HFpEF – What’s New in the Horizon 🗓️ Monday, 13 April 2026 🕗 8:00 – 9:20 PM (KSA Time) 💻 Live Virtual Webinar 📌 2 CME Hours Accredited 🔗 Registration: saudi-heart.com/expanding-hori… #Cardiology #HeartFailure #HFpEF #HFmrEF #CME
Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With LVEF ≥40% 🗓️ Tuesday , 05 May 2026 🕗 8:00 – 9:00 PM (KSA Time) 💻 Live Virtual Webinar 📌 2 CME Hours Accredited 🔗 Registration: saudi-heart.com/treating-patie… #Cardiology #HeartFailure
Participants selected for the Ambulatory Specialty Model for #HeartFailure will be required to collect and submit data on 5 MIPS quality measures – including MIPS #337: Functional Status Assessments For HF. Learn more: bit.ly/4d5bqxc
🆕 #Research | Acute kidney function declines in #HeartFailure — does timing matter? In 3,931 AHF patients (EVEREST trial), creatinine rises at 7 and 14 days — but not 3 days — were linked to greater risk of CV death or HF hospitalization. ⚠️ Kidney declines at all timepoints
We’re looking forward to attending HFA Heart Failure 2026 in Barcelona, Spain, May 9 – 12. We'll be sharing abstracts, sponsoring a satellite symposium, and connecting with attendees at our booth. Learn more: bit.ly/48xWKFj #HeartFailure2026 #HeartFailure
#ACC26 featured several late-breaking #HeartFailure clinical trials, including: 🫀 SPIRIT-HF 🫀 SCOUT-HM 🫀 CADENCE Read the expert analysis to get the details: bit.ly/49gc09W #CardioX #CardioTwitter #ACCHFT
Practice-level compliance with the #heartfailure composite measure as well as individual measures related to beta-blocker and ACE inhibitor/ARB use were associated with decreased risk of death or hospitalization. Read the journal scan for more: bit.ly/4cJEASk #CardioX
Diagnosis of #TransthyretinCardiacAmyloidosis was frequently delayed >6 months after #HeartFailure in Medicare beneficiaries, especially among women and those with aortic stenosis, coronary artery disease, diabetes, or hypertension. ja.ma/4w0buqx
“One of the hardest parts was being a mum and explaining to my children that I’m different now.” Sharon’s #HeartFailure story highlights the reality of living with an invisible condition: not always recognised or understood, but never faced alone. 📖 youtu.be/JonNPeVst1I
🆕 Our meta-analysis is out in @JCardFail In-hospital initiation of #SGLT2i in acute #HeartFailure: ⬇️ All-cause mortality ⬇️ WHF events ⬇️ CV death @JamalRanaMD @robmentz @gcfmd #Cardiology #SGLT2inhibitors #CardioTwitter
Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With LVEF ≥40% 🗓️ Tuesday , 05 May 2026 🕗 8:00 – 9:00 PM (KSA Time) 💻 Live Virtual Webinar 📌 2 CME Hours Accredited 🔗 Registration: saudi-heart.com/treating-patie… #Cardiology #HeartFailure
Heart failure and preserved ejection fraction: pathophysiology, clinical assessment, and management of exercise intolerance. Read this State-of-the-Art review in #EHJ 👉 ow.ly/MoHB50YSgrS @RoccoMontone @ehj_ed #HFpEF
Sex differences in pharmacological treatment of #heartfailure: a meta-analysis of randomized trials Large meta-analysis of 139 HF trials (292k patients) shows #HF therapies work equally well in women and men(Δln[REM] 0.00; 95% CI −0.04–0.03; P=0.85). Yet women made up only
![HanCardiomd's tweet image. Sex differences in pharmacological treatment of #heartfailure: a meta-analysis of randomized trials
Large meta-analysis of 139 HF trials (292k patients) shows #HF therapies work equally well in women and men(Δln[REM] 0.00; 95% CI −0.04–0.03; P=0.85). Yet women made up only](https://pbs.twimg.com/media/HHG_pofXwAAZUPn.jpg)
![HanCardiomd's tweet image. Sex differences in pharmacological treatment of #heartfailure: a meta-analysis of randomized trials
Large meta-analysis of 139 HF trials (292k patients) shows #HF therapies work equally well in women and men(Δln[REM] 0.00; 95% CI −0.04–0.03; P=0.85). Yet women made up only](https://pbs.twimg.com/media/HHG_pohXkAAFOAn.jpg)
![HanCardiomd's tweet image. Sex differences in pharmacological treatment of #heartfailure: a meta-analysis of randomized trials
Large meta-analysis of 139 HF trials (292k patients) shows #HF therapies work equally well in women and men(Δln[REM] 0.00; 95% CI −0.04–0.03; P=0.85). Yet women made up only](https://pbs.twimg.com/media/HHG_poeWwAAMby7.jpg)
From bench to beating hearts ❤️🩹 Japan grants the world’s first approval for iPSC-derived cardiomyocyte therapy—turning Shinya Yamanaka’s discovery into a real treatment for heart failure. @Nature #iPSC #HeartFailure rdcu.be/ff94f
HF research is challenged by patient heterogeneity & variable trial design. HFC-ARC provides consensus definitions to better define subgroups, improve trial design, inform regulation, & advance more precise, patient-centered #heartfailure care. jacc.org/doi/10.1016/j.… #JACCHF
We're proud to partner with Dr. Jonathan Nitz, Dr. Yehoshua Levine, and the team at Methodist University Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure.
Diagnosis of #TransthyretinCardiacAmyloidosis was frequently delayed >6 months after #HeartFailure in Medicare beneficiaries, especially among women and those with aortic stenosis, coronary artery disease, diabetes, or hypertension. ja.ma/4cWMd7O
#HeartFailure is a chronic condition in which the heart muscle becomes weakened and is unable to pump sufficient blood and oxygen to meet the body’s needs. Learn more: bit.ly/4rX1oDu
TOO MUCH CUTENESS!! my heart can’t take it… i quit— heart explosion imminent 💖💥 #cutenessoverload #maidpile #heartfailure #tooadorable #faintincoming #workimpossible
Heart Failure Prevention: Evidence Generation, Trial Design, and Regulatory Pathways (JACC, February 2026) 🔗 jacc.org/doi/10.1016/j.… #CardioTwitter #HeartFailure #Prevention
📅 Save the Date Το 2ο Πανελλήνιο Συνέδριο Καρδιακής Ανεπάρκειας επιστρέφει, συγκεντρώνοντας κορυφαίους επιστήμονες και επαγγελματίες υγείας από όλη την Ελλάδα. 🗓 16–18 Οκτωβρίου 2026 📍 Makedonia Palace, Θεσσαλονίκη #HeartFailure #Cardiology #Thessaloniki #AFEACongress
Takatsubo Cardiomyopathy? Emotional stress induced heart failure. #takatsubo #heartfailure #chf #cardiaccath #cathlab #greenscreen #CardioTwitter #MedTwitter
facebook.com/share/p/1FGk4z… Cardiorenal Pharmacotherapy: Mechanisms and Outcomes 🟥 RAASi — eGFR dip, MACE↓ 🟧 ARNI — NT-proBNP↓ 🟩 SGLT2i — proteinuria↓ 🟦 ns-MRA — fibrosis↓ 🟪 GLP-1 RA — HFH↓ #CardioRenal #HeartFailure #CKD #SGLT2i #ARNI #GLP1RA #Nephrology #Cardiology
Optimizing Outcomes: Evidence-Based Strategies for Treating Patients With Heart Failure With LVEF ≥40% 🗓️ Tuesday , 05 May 2026 🕗 8:00 – 9:00 PM (KSA Time) 💻 Live Virtual Webinar 📌 2 CME Hours Accredited 🔗 Registration: saudi-heart.com/treating-patie… #Cardiology #HeartFailure
Heart Failure with Reduced Ejection Fraction Latest Guidelines and Beyond 🗓️ Saturday, 14 February 2026 🕘 08:00 – 09:30 PM (KSA Time) 💻 Virtual Webinar 📌 2 CME Hours Accredited 🔗 Registration: saudi-heart.com/heart-failure-… #SaudiHeartAssociation #HeartFailure #HFrEF #Cardiology
Expanding Horizons: HFmrEF & HFpEF – What’s New in the Horizon 🗓️ Monday, 13 April 2026 🕗 8:00 – 9:20 PM (KSA Time) 💻 Live Virtual Webinar 📌 2 CME Hours Accredited 🔗 Registration: saudi-heart.com/expanding-hori… #Cardiology #HeartFailure #HFpEF #HFmrEF #CME
#ACC26 featured several late-breaking #HeartFailure clinical trials, including: 🫀 SPIRIT-HF 🫀 SCOUT-HM 🫀 CADENCE Read the expert analysis to get the details: bit.ly/49gc09W #CardioX #CardioTwitter #ACCHFT
Diagnosis of #TransthyretinCardiacAmyloidosis was frequently delayed >6 months after #HeartFailure in Medicare beneficiaries, especially among women and those with aortic stenosis, coronary artery disease, diabetes, or hypertension. ja.ma/4w0buqx
🆕 #Research | Acute kidney function declines in #HeartFailure — does timing matter? In 3,931 AHF patients (EVEREST trial), creatinine rises at 7 and 14 days — but not 3 days — were linked to greater risk of CV death or HF hospitalization. ⚠️ Kidney declines at all timepoints
Simultaneous publication during #EHRA26 👇 Subclinical #afib and the risk of #HeartFailure: insights from ARTESiA ow.ly/H1Qp50YI7mz @EJHFEiC #EJHF
Endomyocardial biopsy plays a pivotal role in the diagnostic workup of myocarditis, cardiomyopathies, and unexplained acute heart failure. Careful patient selection and expertise are essential to optimise its risk–benefit profile. #cardiotwitter #heartfailure #cardiology 👉Read
Conversational #ArtificialIntelligence for remote monitoring in #HeartFailure: a prospective controlled pilot study ow.ly/aYEo50YqPXj #EHJDigital #NLP @BruiningNico @rafavidalperez @fwasselbergs @rbcasado @HFA_President
#HeartFailure (HF) affects more than 64 million individuals worldwide, and acute HF is associated with 1-year mortality rates of 23.6% in North America and Europe. Cardiac resynchronization therapy restores synchronous ventricular activation in patients with HF, reduced LVEF,
HF research is challenged by patient heterogeneity & variable trial design. HFC-ARC provides consensus definitions to better define subgroups, improve trial design, inform regulation, & advance more precise, patient-centered #heartfailure care. jacc.org/doi/10.1016/j.… #JACCHF
The Clinical value of circadian biofeedback in chronic #HeartFailure ow.ly/iBsJ50Yr9PI #EHJDigital #wearables #mHealth @BruiningNico @rafavidalperez @fwasselbergs @rbcasado @HFA_President
🫀 Why do so many #HeartFailure patients never reach optimal medical therapy? Quadruple therapy (BB + RASi/ARNi + MRA + SGLT2i) is guideline-recommended for #HFrEF — yet adherence gaps remain a critical challenge. Barriers are multilayered: 🩺 Physician → guideline awareness,
Causal role of adipose tissue-derived adipokines in the pathogenesis of #HFpEF: experimental demonstration as the basis for clinical targeting. Read this interesting hypothesis in #EHJ 👉 ow.ly/9yFg50Yra2R @RoccoMontone @ehj_ed #heartfailure
Physician-directed patient self-management using ambulatory IVC-based congestion monitoring was feasible, assoc w/ increased signal-driven intervention, and not assoc w/ adverse safety signals. jacc.org/doi/10.1016/j.… #JACCHF #THT2026 #HeartFailure
Left-sided Vs Right-sided Heart Failure #heartfailure #Nursing #Nclex #PNLE #MedTwt #NursingTwt #MedX
Heart Failure Prevention: Evidence Generation, Trial Design, and Regulatory Pathways #heartfailure #heartfailureawareness #CVprev @JavedButler1 #functionnotfailure 🙏🏽 for including me in this important paper leading the pathway ahead @JACCJournals 📎 shorturl.at/Omv9e
1 in 4 will develop heart failure… yet we barely define prevention. Are we measuring the wrong outcomes entirely? 🤔 jacc.org/doi/10.1016/j.… #JACC #cvPrev #HeartFailure @NicolasGirerd @UnIC_cardiovasc @ShahzebKhanMD @mvaduganathan
Baseline #NTproBNP was independently assoc w/ 2-yr mortality or #heartfailure hospitalization after T-#TEER. Early post-procedural NT-proBNP trajectories provided incremental prognostic information & may identify pts at increased risk. jacc.org/doi/10.1016/j.… #JACCINT #THT2026
Something went wrong.
Something went wrong.
United States Trends
- 1. Jokic N/A
- 2. Jaden McDaniels N/A
- 3. Nuggets N/A
- 4. Wolves N/A
- 5. Adelman N/A
- 6. Celtics N/A
- 7. Oilers N/A
- 8. Christian Braun N/A
- 9. Knicks N/A
- 10. #FlyTogether N/A
- 11. Rudy Gobert N/A
- 12. Cam Johnson N/A
- 13. Hawks N/A
- 14. McDavid N/A
- 15. Game 7 N/A
- 16. Scott Jennings N/A
- 17. Chris Finch N/A
- 18. Tatum N/A
- 19. Sixers N/A
- 20. No Ant N/A